TNXP vs XLK
Tonix Pharmaceuticals Holding Corp (TNXP) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported TNXP revenue for 2026-06-30 was $20.4M. Net income was -$80.7M. TNXP currently screens at market cap $194.5M.
XLK does not have a complete income-statement cache yet.
TNXP currently screens at market cap $194.5M. XLK currently screens at market cap $0.
Not investment advice. Open the TNXP and XLK stock pages for the full models.
Not investment advice.